PREDICTORS OF CLINICAL RESPONSE AND INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IMPROVEMENT WITH GOLIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS IN THE PURSUIT-MAINTENANCE STUDY

Cindy LJ Weinstein  ¹     Jianxin Lin     Alan Meehan     Marinella Govoni  ²     Zaina P Qureshi    
¹ Merck & Co., Inc., Kenilworth, United States
² MSD Italy, Rome, Italy

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)